Italia markets closed

ILMN Dec 2024 250.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,25000,0000 (0,00%)
Alla chiusura: 09:30AM EDT
Schermo intero
Chiusura precedente2,2500
Aperto2,2500
Denaro0,0000
Lettera0,0000
Prezzo d'esercizio250,00
Scadenza2024-12-20
Min-Max giorno2,2500 - 2,2500
Contratto - Min-MaxN/D
Volume1
Open Interest6
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera